Alan Crane

Co-Founder at Pandion Therapeutics, Inc.

Alan Crane

Alan Crane

Co-Founder at Pandion Therapeutics, Inc.

Overview
Career Highlights

Calorics Pharmaceuticals
Momenta Pharmaceuticals, Inc.
Pandion Therapeutics, Inc.

RelSci Relationships

3771

Number of Boards

21

Birthday

1964

Age

56

Contact Data
Trying to get in touch with Alan Crane? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Alan Crane likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Scientific Founder at Visterra, Inc.

Relationship likelihood: Strong

Co-Founder at Lyndra Therapeutics, Inc.

Relationship likelihood: Strong

Partner at Polaris Partners

Relationship likelihood: Strong

Partner at Atlas Venture, Inc.

Relationship likelihood: Strong

Founding Partner at Polaris Partners

Relationship likelihood: Strong

Co-Founder at Seventh Sense Biosystems, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer, Director at Visterra, Inc.

Relationship likelihood: Strong

Founding Partner at Polaris Partners

Relationship likelihood: Strong

Managing Partner at Polaris Partners

Relationship likelihood: Strong

Paths to Alan Crane
Potential Connections via
Relationship Science
You
Alan Crane
Co-Founder at Pandion Therapeutics, Inc.
Education
Career History
Co-Founder
2016 - Current

Pandion Therapeutics, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA.

Chief Executive Officer, Co-Founder
2011 - Current

XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical Products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA.

Entrepreneur Partner
2002 - Current

Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies.The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software.In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services.Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services.Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.

Boards & Committees
Chairman
Prior
Director
Prior
Director
Prior
Member, Board of Trustees
Current
President
Tenure Unconfirmed
Director
Tenure Unconfirmed
Political Donations
$1,500
2008
Transactions
Details Hidden

XTuit Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

Pandion Therapeutics, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Eagle Biologics, Inc. provides bio technological solutions. It develops protein-based antibody drugs by use of technology. The company was founded by Alan L. Crane, Alex Klibanov, and Robert S. Langer Jr. in 2013 and is headquartered in Cambridge, MA.

Details Hidden

Visterra, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 26, 2007 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alan Crane. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alan Crane's profile does not indicate a business or promotional relationship of any kind between RelSci and Alan Crane.